406 results on '"Murphy, Declan"'
Search Results
2. Case of the Month from the Peter MacCallum Cancer Centre, Melbourne, Australia: an operative approach to large renal angiomyolipoma associated with lymphangioleiomyomatosis
3. The pen is mightier than the machine—artificial intelligence image generators in urology
4. How prostate‐specific membrane antigen positron emission tomography is refining risk calculators in the primary prostate diagnostic pathway
5. Barriers and enablers of active surveillance for prostate cancer: a qualitive study of clinicians
6. Comments
7. Proton therapy websites: information anarchy creates confusion.
8. The Melbourne Consensus Statement on the early detection of prostate cancer.
9. Treatment de‐intensification for low‐risk biochemical recurrence after radical prostatectomy: rational or risky?
10. Decade‐long trends in prostate cancer biopsy grade groups and treatment within a population‐based registry
11. Synchronous versus independent reading of PSMA‐PET and MRI to improve diagnosis for prostate cancer
12. Synchronous vs independent reading of prostate‐specific membrane antigen positron emission tomography (PSMA‐PET) and magnetic resonance imaging (MRI) to improve diagnosis of prostate cancer.
13. Active surveillance versus enzalutamide for low‐risk prostate cancer – was it really a trial we needed?
14. Prostate‐specific membrane antigen positron emission tomography/computed tomography funding grants free access to superior staging for Australian men with prostate cancer
15. STAMPEDE‐ing towards androgen biosynthesis inhibition for treatment of high‐risk hormone‐naïve prostate cancer: changing the LATITUDE
16. Stereotactic ablative body radiotherapy for inoperable primary kidney cancer: a prospective clinical trial
17. High prostate‐specific membrane antigen ( PSMA) positron emission tomography (PET) maximum standardized uptake value in men with PI‐RADS score 4 or 5 confers a high probability of significant prostate cancer
18. Large variation in conservative management of low‐risk prostate cancer in Australia and New Zealand
19. Bringing clarity or confusion? The role of prostate-specific membrane antigen positron-emission/computed tomography for primary staging in prostate cancer
20. The impact of the United States Preventive Services Task Force (USPTSTF) recommendations against prostate‐specific antigen (PSA) testing on PSA testing in Australia
21. Prostate Imaging Reporting and Data System score of four or more: active surveillance no more
22. The urologistʼs role in multidisciplinary management of placenta percreta
23. Patterns-of-care and health economic analysis of robot-assisted radical prostatectomy in the Australian public health system
24. Gleason pattern 4: active surveillance no more
25. Training in minimally invasive surgery in urology: European Association of Urology/International Consultation of Urological Diseases consultation
26. Emerging trends in prostate cancer literature: medical progress or marketing hype?
27. Online and social media presence of Australian and New Zealand urologists
28. Patients with medical risk factors for chronic kidney disease are at increased risk of renal impairment despite the use of nephron-sparing surgery
29. Transperineal biopsy prostate cancer detection in first biopsy and repeat biopsy after negative transrectal ultrasound-guided biopsy: the Victorian Transperineal Biopsy Collaboration experience
30. ‘Lets talk about sex’: a prospective audit of a Nurse Practitioner-led sexual health and erectile dysfunction (SHED) Clinic: 137
31. ASTROID (Active Surveillance and other Treatment Options for Prostate Cancer): a decision aid: 107
32. Oncological and functional outcomes of laparoscopic radical prostatectomies (LRP) - findings in the Victorian Prostate Cancer Registry (PCR): 175
33. Neurovascular bundle stimulation results in rhabdosphincter contraction in a proportion of men undergoing radical prostatectomy: 196
34. Evaluation of detection rate of 68Ga-PSMA-ligand PET/CT for biochemical recurrence after radical prostatectomy: 197
35. Open versus robotic-assisted radical prostatectomies in the Victorian prostate cancer registry (PCR) - analysis at 2-year follow-up: 128
36. Quality of life of patients having transperineal biopsies for the diagnosis of prostate cancer: 101
37. Rates and predictive factors of Gleason score upgrade in a cohort of Australian men undergoing robotic-assisted radical prostatectomy: 086
38. Welcome for PCWC BJUI supplement A global perspective from the Prostate Cancer World Congress
39. Targeted local therapy in oligometastatic prostate cancer: a promising potential opportunity after failed primary treatment
40. Development of a standardised training curriculum for robotic surgery: a consensus statement from an international multidisciplinary group of experts
41. The social media revolution is changing the conference experience: analytics and trends from eight international meetings
42. Transperineal prostate biopsy: template-guided or freehand?
43. The current use of active surveillance in an Australian cohort of men: a pattern of care analysis from the Victorian Prostate Cancer Registry
44. The emerging use of Twitter by urological journals
45. Racing ahead
46. Positive surgical margins: rate, contributing factors and impact on further treatment: findings from the Prostate Cancer Registry
47. Early urinary continence recovery after robot-assisted radical prostatectomy in older Australian men
48. Sepsis and ‘superbugs’: should we favour the transperineal over the transrectal approach for prostate biopsy?
49. UpFrontPSMA: a randomized phase 2 study of sequential 177 Lu‐PSMA‐617 and docetaxel vs docetaxel in metastatic hormone‐naïve prostate cancer (clinical trial protocol)
50. Management of patients who opt for radical prostatectomy during the coronavirus disease 2019 (COVID‐19) pandemic: an international accelerated consensus statement
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.